CellaVision AB
STO:CEVI
CellaVision AB
Revenue
CellaVision AB
Revenue Peer Comparison
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
CellaVision AB
STO:CEVI
|
Revenue
kr677.3m
|
CAGR 3-Years
13%
|
CAGR 5-Years
13%
|
CAGR 10-Years
14%
|
|
Elekta AB (publ)
STO:EKTA B
|
Revenue
kr16.9B
|
CAGR 3-Years
5%
|
CAGR 5-Years
8%
|
CAGR 10-Years
N/A
|
|
Getinge AB
STO:GETI B
|
Revenue
kr31.8B
|
CAGR 3-Years
2%
|
CAGR 5-Years
6%
|
CAGR 10-Years
N/A
|
|
Arjo AB (publ)
STO:ARJO B
|
Revenue
kr11B
|
CAGR 3-Years
7%
|
CAGR 5-Years
6%
|
CAGR 10-Years
N/A
|
|
Elos Medtech AB
STO:ELOS B
|
Revenue
kr888.5m
|
CAGR 3-Years
9%
|
CAGR 5-Years
9%
|
CAGR 10-Years
N/A
|
|
Sedana Medical AB (publ)
STO:SEDANA
|
Revenue
kr153.9m
|
CAGR 3-Years
3%
|
CAGR 5-Years
22%
|
CAGR 10-Years
N/A
|
See Also
What is CellaVision AB's Revenue?
Revenue
677.3m
SEK
Based on the financial report for Dec 31, 2023, CellaVision AB's Revenue amounts to 677.3m SEK.
What is CellaVision AB's Revenue growth rate?
Revenue CAGR 10Y
14%
Over the last year, the Revenue growth was 6%. The average annual Revenue growth rates for CellaVision AB have been 13% over the past three years , 13% over the past five years , and 14% over the past ten years .